At 35 days post-treatment, tumor weight reduced by 72.0% compared with the control group coinciding with increased TUNEL-positive cells, decreased Bcl-2 protein expression, increased Bax protein expression, induction of JNK/SAPK phosphorylation, and AIF nuclear translocation in the tumors of the cambogin-treated mice. This evidence concerns the gene BAX and neoplasm.